Cosciens Biopharma Stock Technical Analysis
| CSCI Stock | 2.06 0.18 9.57% |
As of the 14th of February 2026, COSCIENS Biopharma shows the mean deviation of 6.9, and Risk Adjusted Performance of 0.0168. COSCIENS Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
COSCIENS Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as COSCIENS, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to COSCIENSCOSCIENS Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Biotechnology market expansion? Will COSCIENS introduce new products? Factors like these will boost the valuation of COSCIENS Biopharma. Projected growth potential of COSCIENS fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.54) | Revenue Per Share | Quarterly Revenue Growth 0.176 | Return On Assets | Return On Equity |
Understanding COSCIENS Biopharma requires distinguishing between market price and book value, where the latter reflects COSCIENS's accounting equity. The concept of intrinsic value - what COSCIENS Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push COSCIENS Biopharma's price substantially above or below its fundamental value.
It's important to distinguish between COSCIENS Biopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding COSCIENS Biopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, COSCIENS Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
COSCIENS Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to COSCIENS Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of COSCIENS Biopharma.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in COSCIENS Biopharma on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding COSCIENS Biopharma or generate 0.0% return on investment in COSCIENS Biopharma over 90 days. COSCIENS Biopharma is related to or competes with Biora Therapeutics, CervoMed, and Tvardi Therapeutics. COSCIENS Biopharma is entity of United States More
COSCIENS Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure COSCIENS Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess COSCIENS Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 14.61 | |||
| Information Ratio | 0.0042 | |||
| Maximum Drawdown | 94.83 | |||
| Value At Risk | (28.04) | |||
| Potential Upside | 27.11 |
COSCIENS Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for COSCIENS Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as COSCIENS Biopharma's standard deviation. In reality, there are many statistical measures that can use COSCIENS Biopharma historical prices to predict the future COSCIENS Biopharma's volatility.| Risk Adjusted Performance | 0.0168 | |||
| Jensen Alpha | 0.1062 | |||
| Total Risk Alpha | (0.93) | |||
| Sortino Ratio | 0.004 | |||
| Treynor Ratio | 0.5595 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of COSCIENS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
COSCIENS Biopharma February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0168 | |||
| Market Risk Adjusted Performance | 0.5695 | |||
| Mean Deviation | 6.9 | |||
| Semi Deviation | 11.21 | |||
| Downside Deviation | 14.61 | |||
| Coefficient Of Variation | 10944.79 | |||
| Standard Deviation | 14.11 | |||
| Variance | 199.21 | |||
| Information Ratio | 0.0042 | |||
| Jensen Alpha | 0.1062 | |||
| Total Risk Alpha | (0.93) | |||
| Sortino Ratio | 0.004 | |||
| Treynor Ratio | 0.5595 | |||
| Maximum Drawdown | 94.83 | |||
| Value At Risk | (28.04) | |||
| Potential Upside | 27.11 | |||
| Downside Variance | 213.34 | |||
| Semi Variance | 125.68 | |||
| Expected Short fall | (8.88) | |||
| Skewness | 1.34 | |||
| Kurtosis | 7.0 |
COSCIENS Biopharma Backtested Returns
COSCIENS Biopharma appears to be abnormally volatile, given 3 months investment horizon. COSCIENS Biopharma secures Sharpe Ratio (or Efficiency) of 0.0271, which signifies that the company had a 0.0271 % return per unit of volatility over the last 3 months. We have found twenty-seven technical indicators for COSCIENS Biopharma, which you can use to evaluate the volatility of the firm. Please makes use of COSCIENS Biopharma's risk adjusted performance of 0.0168, and Mean Deviation of 6.9 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, COSCIENS Biopharma holds a performance score of 2. The firm shows a Beta (market volatility) of 0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, COSCIENS Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding COSCIENS Biopharma is expected to be smaller as well. Please check COSCIENS Biopharma's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether COSCIENS Biopharma's price patterns will revert.
Auto-correlation | -0.17 |
Insignificant reverse predictability
COSCIENS Biopharma has insignificant reverse predictability. Overlapping area represents the amount of predictability between COSCIENS Biopharma time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of COSCIENS Biopharma price movement. The serial correlation of -0.17 indicates that over 17.0% of current COSCIENS Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.17 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
COSCIENS Biopharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for COSCIENS Biopharma across different markets.
About COSCIENS Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of COSCIENS Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of COSCIENS Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on COSCIENS Biopharma price pattern first instead of the macroeconomic environment surrounding COSCIENS Biopharma. By analyzing COSCIENS Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of COSCIENS Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to COSCIENS Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 (projected) | Payables Turnover | 15.04 | 2.9 | 2.61 | Days Of Inventory On Hand | 347.99 | 140.63 | 161.73 |
COSCIENS Biopharma February 14, 2026 Technical Indicators
Most technical analysis of COSCIENS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for COSCIENS from various momentum indicators to cycle indicators. When you analyze COSCIENS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0168 | |||
| Market Risk Adjusted Performance | 0.5695 | |||
| Mean Deviation | 6.9 | |||
| Semi Deviation | 11.21 | |||
| Downside Deviation | 14.61 | |||
| Coefficient Of Variation | 10944.79 | |||
| Standard Deviation | 14.11 | |||
| Variance | 199.21 | |||
| Information Ratio | 0.0042 | |||
| Jensen Alpha | 0.1062 | |||
| Total Risk Alpha | (0.93) | |||
| Sortino Ratio | 0.004 | |||
| Treynor Ratio | 0.5595 | |||
| Maximum Drawdown | 94.83 | |||
| Value At Risk | (28.04) | |||
| Potential Upside | 27.11 | |||
| Downside Variance | 213.34 | |||
| Semi Variance | 125.68 | |||
| Expected Short fall | (8.88) | |||
| Skewness | 1.34 | |||
| Kurtosis | 7.0 |
COSCIENS Biopharma February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as COSCIENS stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.10 | ||
| Day Median Price | 2.06 | ||
| Day Typical Price | 2.06 | ||
| Price Action Indicator | 0.09 |
Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |